Citation 77906

KOBAYASHI,J: TSUDA,M: FUSE,H: SASAKI,T: MIKAMI,Y:. (1997). HALISHIGAMIDES A-D, NEW CYTOTOXIC OXAZOLE-CONTAINING METABOLITES FROM OKINAWAN SPONGE HALICHONDRIA SP.. 60(2)

Citation Details

Title	HALISHIGAMIDES A-D, NEW CYTOTOXIC OXAZOLE-CONTAINING METABOLITES FROM OKINAWAN SPONGE HALICHONDRIA SP.
Authors	KOBAYASHI,J: TSUDA,M: FUSE,H: SASAKI,T: MIKAMI,Y:
Year	1997
Volume	60
Issue	2

Summary

Year: 1997

Journal: Unknown

Organisms and Their Experiments (1)

Halichondria species (AXINELLIDAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HALISHIGAMIDE A	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISHIGAMIDE A	STRONG ACTIVITY
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISHIGAMIDE A	STRONG ACTIVITY
4	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HALISHIGAMIDE A	ACTIVE
5	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDPAPER CHROMATOGRAPHY DATA REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HALISHIGAMIDE B	None
6	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HALISHIGAMIDE C	None
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISHIGAMIDE B	WEAK ACTIVITY
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISHIGAMIDE B	WEAK ACTIVITY
9	FIBRINOLYTIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HALISHIGAMIDE B	ACTIVE
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISHIGAMIDE C	WEAK ACTIVITY
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISHIGAMIDE C	WEAK ACTIVITY
12	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HALISHIGAMIDE C	ACTIVE
13	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HALISHIGAMIDE D	None
14	Not specified	ISOLATION AND IDENTIFICATION OF	HALICHONDRAMIDE	None
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISHIGAMIDE D	ACTIVE
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HALISHIGAMIDE D	ACTIVE
17	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	HALISHIGAMIDE D	ACTIVE
18	Not specified	ISOLATION AND IDENTIFICATION OF	HALICHONDRAMIDE ESTER	None

Show SPARQL Queries (1)